Cite
APA Citation
Deva, S., Lee, J., Lin, C., Yen, C., Millward, M., Chao, Y., Keam, B., Jameson, M., Hou, M., Kang, Y., Markman, B., Lu, C., Rau, K., Lee, K., Horvath, L., Friedlander, M., Hill, A., Wu, J., Hou, J., & Desai, J. (n.d.). 70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095501161.0x000035